Basisstatistiken
| CIK | 1734750 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Corvex, Inc.
SEC Filings (Chronological Order)
Auf dieser Seite finden Sie eine vollständige, chronologische Liste der SEC-Einreichungen, mit Ausnahme der Eigentumseinreichungen, die wir an anderer Stelle bereitstellen.
| May 27, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Co |
|
| May 19, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2026 CORVEX, INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 19, 2026 |
Corvex, Inc. Summary Historical and Pro Forma Consolidated Financial Data Exhibit 99.1 Corvex, Inc. Summary Historical and Pro Forma Consolidated Financial Data The amounts in this unaudited pro forma condensed combination financial information are presented in thousands of U.S. dollars except share and per share amounts. Introductory Note On March 19, 2026, Corvex, Inc. (formerly known as Movano Inc.) (the “Company” or “Corvex”), acquired Corvex Legacy Holdings, Inc. ( |
|
| May 19, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2026 CORVEX, INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 19, 2026 |
UNAUDITED SUPPLEMENTAL NON-GAAP FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED SUPPLEMENTAL NON-GAAP FINANCIAL INFORMATION Corvex, Inc. (the “Company”) is furnishing the following information regarding the Adjusted EBITDA of the Company on a pro forma basis for the three months ended March 31, 2026 and for the year ended December 31, 2025 (collectively, “Adjusted EBITDA”), to supplement the unaudited pro forma condensed combined financial information o |
|
| May 19, 2026 |
Exhibit 99.1 Corvex Reports Q1 2026 Financial Results and Provides Business Update Conference Call at 4:30 PM ET / 1:30 PM PT ARLINGTON, Va., May 19, 2026 - Corvex, Inc. (Nasdaq:MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, reported first quarter 2026 results and provided a business update. Reported Q1’26 Highlights: ● Completed ac |
|
| May 19, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 CORVEX, INC. (Exact name of registrant as s |
|
| May 18, 2026 |
SEC File Number 001-40254 CUSIP Number 662459M 305 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 1, 2026 |
Exhibit 99.2 Corvex Legacy Holdings, Inc. (f.k.a Corvex, Inc.) Financial Statements of Corvex Legacy Holdings December 31, 2025 and 2024 and for the Year Ended December 31, 2025 and for the Period from October 21 (Inception) through December 31, 2024 Index to Financial Statements REPORT OF INDEPENDENT AUDITOR 1 BALANCE SHEETS 3 STATEMENTS OF OPERATIONS 4 STATEMENTS OF CONVERTIBLE PREFERRED STOCK A |
|
| May 1, 2026 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Prox |
|
| May 1, 2026 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The amounts in this unaudited pro forma condensed combination financial information are presented in thousands of U.S. dollars except share and per share amounts. Introductory Note On March 19, 2026, Corvex, Inc. (formerly known as Movano Inc.) (the “Company” or “Corvex”), acquired Corvex Legacy Holdings, Inc. (formerly know |
|
| May 1, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2026 (March 18, 2026) CORVEX, INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of inco |
|
| April 28, 2026 |
Exhibit 10.15 KLUSTR, INC. 2024 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: November 5, 2024 APPROVED BY THE STOCKHOLDERS: November 5, 2024 TERMINATION DATE: November 4, 2034 1. General. (a) Eligible Stock Award Recipients. Employees, Directors and Consultants are eligible to receive Stock Awards. (b) Available Stock Awards. The Plan provides for the grant of the following types of St |
|
| April 28, 2026 |
Exhibit 4.6 DESCRIPTION OF COMMON STOCK OF CORVEX, INC. REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a brief description of our common stock. This summary does not purport to be complete in all respects. This description is subject to and qualified entirely by the terms of our Third Amended and Restated Certificate of Incorporation (the “Certificate of |
|
| April 28, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 |
|
| April 28, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2026 CORVEX, INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number |
|
| April 28, 2026 |
California Office: 101 Larkspur Landing Cir Suite 321 Larkspur, CA 94939 Exhibit 16.1 California Office: 101 Larkspur Landing Cir Suite 321 Larkspur, CA 94939 www.rbsmllp.com April 28, 2026 Securities and Exchange Commission 100 F Street, N.W. Washington, DC 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of the Corvex, Inc. (the "Company") Form 8-K dated April 28, 2026, and are in agreement with the statements relating only to RBSM, LLP contained therein. We have |
|
| April 9, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2026 CORVEX, INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| March 31, 2026 |
Corvex, Inc. Insider Trading Policy Exhibit 19.1 Corvex, Inc. Insider Trading Policy Purpose Corvex, Inc. (the “Company”) has adopted this Insider Trading Policy (the “Policy”) to promote compliance with federal securities laws and regulations adopted by the Securities and Exchange Commission (the “SEC”) by directors, officers, employees and consultants of the Company and its affiliates, as well as any immediate family members shari |
|
| March 31, 2026 |
Exhibit 21.1 SUBSIDIARIES OF MOVANO INC. Registrant’s consolidated subsidiaries are shown below, together with the state or jurisdiction of organization of each subsidiary and the percentage of voting securities that Registrant owns in each subsidiary. Name of Subsidiary Jurisdiction of Incorporation or Organization Percent of Outstanding Voting Securities Owned as of March 23, 2026 Movano Ireland |
|
| March 31, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 CORVEX, INC. (Exa |
|
| March 31, 2026 |
Exhibit 2.2 EXECUTION VERSION AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER by and among: MOVANO INC., a Delaware corporation, THOR MERGER SUB INC., a Delaware corporation, and CORVEX, INC., a Delaware corporation Made and entered into as of March 19, 2026 TABLE OF CONTENTS Page Section 1. DESCRIPTION OF TRANSACTION 2 1.1. The Merger 2 1.2. Effects of the Merger 2 1.3. Closing; Effective Time |
|
| March 31, 2026 |
CORVEX, INC. Incentive-BASED Compensation Recovery Policy Exhibit 97.1 CORVEX, INC. Incentive-BASED Compensation Recovery Policy 1. Policy Purpose. The purpose of this Incentive-Based Compensation Recovery Policy (this “Policy”) of Corvex, Inc. (the “Company”) is to enable the Company to recover Erroneously Awarded Compensation (as defined below) in the event that the Company is required to prepare an Accounting Restatement. This Policy is intended to co |
|
| March 19, 2026 |
SECOND AMENDED AND RESTATED BYLAWS OF Corvex, INC. ARTICLE I Meeting of Stockholders Exhibit 3.5 SECOND AMENDED AND RESTATED BYLAWS OF Corvex, INC. ARTICLE I Meeting of Stockholders Section 1.1. Annual Meetings. If required by applicable law, an annual meeting of stockholders shall be held for the election of directors at such date, time and place, if any, either within or without the State of Delaware, as may be designated by resolution of the board of directors (the “Board of Di |
|
| March 19, 2026 |
FORM OF INDEMNIFICATION AGREEMENT CORVEX, INC. Exhibit 10.7 FORM OF INDEMNIFICATION AGREEMENT FOR CORVEX, INC. This Indemnification Agreement (this “Agreement”) is effective as of , 2026, between Corvex, Inc. (formerly known as Movano Inc.), a Delaware corporation (the “Company”), and (“Indemnitee”). RECITALS A. Indemnitee’s service to the Company substantially benefits the Company. B. Individuals are reluctant to serve as directors or officer |
|
| March 19, 2026 |
CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES C NON-VOTING CONVERTIBLE PREFERRED STOCK Exhibit 3.2 CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES C NON-VOTING CONVERTIBLE PREFERRED STOCK Movano Inc., a Delaware corporation (hereinafter called the “Corporation”), DOES HEREBY CERTIFY hereby certifies that the following resolution has been duly adopted by the Board of Directors of the Corporation (the “Board”) as required by Section 151 of the General Corporation Law of the State of |
|
| March 19, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2026 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| March 19, 2026 |
Movano Inc. 6800 Koll Center Parkway Pleasanton, CA 94566 Movano Inc. 6800 Koll Center Parkway Pleasanton, CA 94566 March 19, 2026 VIA EDGAR CORRESPONDENCE U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Attention: Marion Graham; Larry Spirgel Re: Movano Inc. Request to Withdraw Registration Statement on Form S-4 Filed December 22, 2025, as amended on February 5, 2026 File No. 333-292321 La |
|
| March 19, 2026 |
THIRD AMENDMENT TO LOAN AGREEMENT Exhibit 10.3 THIRD AMENDMENT TO LOAN AGREEMENT THIS THIRD AMENDMENT TO LOAN AGREEMENT (this “Amendment”) is made and entered into as of March 19, 2026, by and between EVIE HOLDINGS, LLC (“Lender”) and MOVANO Inc., a Delaware corporation (the “Borrower”). RECITALS A. On August 5, 2025, Lender made a loan to Borrower in the original principal amount of One Million Five Hundred Thousand Dollars ($1,5 |
|
| March 19, 2026 |
Exhibit 2.1 EXECUTION VERSION AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER by and among: MOVANO INC., a Delaware corporation, THOR MERGER SUB INC., a Delaware corporation, and CORVEX, INC., a Delaware corporation Made and entered into as of March 19, 2026 TABLE OF CONTENTS Page Section 1. DESCRIPTION OF TRANSACTION 2 1.1. The Merger 2 1.2. Effects of the Merger 2 1.3. Closing; Effective Time |
|
| March 19, 2026 |
Exhibit 3.4 STATE OF DELAWARE CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. Pursuant to Section 242 of the General Corporation Law of the State of Delaware, Movano Inc. (the “Corporation”), a corporation duly organized and existing under the General Corporation Law of the State of Delaware does hereby certify: 1. The name of the corporation is M |
|
| March 19, 2026 |
Corvex, Inc. Director Compensation Policy Exhibit 10.4 Corvex, Inc. Director Compensation Policy Members of the Board of Directors (the “Board”) of Corvex, Inc. (the “Company”) who are not employees of the Company or any subsidiary of the Company (“non-employee directors”) shall receive compensation for their services on the Board in accordance with this Director Compensation Policy (this “Policy”). Cash Compensation Each non-employee dir |
|
| March 19, 2026 |
CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES D NON-VOTING CONVERTIBLE PREFERRED STOCK Exhibit 3.3 CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES D NON-VOTING CONVERTIBLE PREFERRED STOCK Movano Inc., a Delaware corporation (hereinafter called the “Corporation”), DOES HEREBY CERTIFY hereby certifies that the following resolution has been duly adopted by the Board of Directors of the Corporation (the “Board”) as required by Section 151 of the General Corporation Law of the State of |
|
| March 19, 2026 |
CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES B CONVERTIBLE PREFERRED STOCK Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES B CONVERTIBLE PREFERRED STOCK Movano Inc., a Delaware corporation (hereinafter called the “Corporation”), DOES HEREBY CERTIFY hereby certifies that the following resolution has been duly adopted by the Board of Directors of the Corporation (the “Board”) as required by Section 151 of the General Corporation Law of the State of Delaware ( |
|
| March 19, 2026 |
CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER Exhibit 99.1 CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER ● Upon the 2026 Stockholders’ Meeting to be held in May 2026, subject to approval by the stockholders and board of directors of the Company, Corvex will be led by Jay Crystal and Seth Demsey as Co-Chief Executive Officers, Co-Founders and Directors. ● Movano Inc. to be renamed Corvex, Inc. and continue to trade on The Nasdaq Stock Market un |
|
| March 19, 2026 |
EXECUTIVE EMPLOYMENT AGREEMENT Exhibit 10.6 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) dated as of March 19, 2026 (the “Effective Date”), is entered by and between Corvex, Inc. (the “Company”), and Jay Crystal (“Executive”). Each of the Company and Executive are a “Party,” and collectively, they are the “Parties.” WHEREAS, in connection with the Amended and Restated Agreement and Plan |
|
| March 19, 2026 |
Exhibit 10.5 EXECUTIVE AGREEMENT This EXECUTIVE AGREEMENT (this “Agreement”) dated as of March 19, 2026 (the “Effective Date”), is entered by and between Corvex, Inc. (the “Company”), and Seth Demsey (“Executive”). Each of the Company and Executive are a “Party,” and collectively, they are the “Parties.” WHEREAS, in connection with the Amended and Restated Agreement and Plan of Merger, dated March |
|
| March 13, 2026 |
Filed by Movano Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Movano Inc. Commission File No.: 001-40254 Date: March 12, 2026 FOR IMMEDIATE RELEASE Corvex Launches Secure Model Weights, Delivering Hardware-Enforced Protection for AI Inference on Third-Party Infrastructure Patent-pending |
|
| March 4, 2026 |
Filed by Movano Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Movano Inc. Commission File No.: 001-40254 Date: March 3, 2026 Corvex Among the First Companies to Achieve Verified Production Deployment of Confidential Computing for AI on NVIDIA HGX™ B200 Systems Encrypted NVIDIA NVSwitch |
|
| February 19, 2026 |
MOVANO INC. 545,456 Shares of Common Stock Filed Pursuant to Rule 424(b)(7) Registration No. 333-292707 PROSPECTUS MOVANO INC. 545,456 Shares of Common Stock This prospectus relates to the potential offer and resale, from time to time by the selling stockholders named in this prospectus (the “Selling Stockholders”), of up to 545,456 shares of common stock, par value $0.0001 (the “Common Stock”) of Movano Inc. (“we”, “us”, “our”, the “Compa |
|
| February 12, 2026 |
As filed with the Securities and Exchange Commission on February 12, 2026. As filed with the Securities and Exchange Commission on February 12, 2026. Registration No. 333-292707 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 3845 82-4233771 (State or other jurisdiction of (Primary Standard |
|
| February 9, 2026 |
As filed with the Securities and Exchange Commission on February 9, 2026. As filed with the Securities and Exchange Commission on February 9, 2026. Registration No. 333- 292322 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 3845 82-4233771 (State or other jurisdiction of (Primary Standard |
|
| February 5, 2026 |
AMENDED AND RESTATED BYLAWS OF Corvex, INC. ARTICLE I Meeting of Stockholders Exhibit 3.9 AMENDED AND RESTATED BYLAWS OF Corvex, INC. ARTICLE I Meeting of Stockholders Section 1.1. Annual Meetings. If required by applicable law, an annual meeting of stockholders shall be held for the election of directors at such date, time and place, if any, either within or without the State of Delaware, as may be designated by resolution of the board of directors (the “Board of Directors |
|
| February 5, 2026 |
As filed with the U.S. Securities and Exchange Commission on February 4, 2026 As filed with the U.S. Securities and Exchange Commission on February 4, 2026 Registration No. 333-292321 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 3845 82-4233771 (State or other jurisdiction of incorporation |
|
| February 5, 2026 |
INDEMNIFICATION AGREEMENT FOR CORVEX, INC. Exhibit 10.33 INDEMNIFICATION AGREEMENT FOR CORVEX, INC. This Indemnification Agreement (this “Agreement”) is effective as of , between Corvex, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”). RECITALS A. Indemnitee’s service to the Company substantially benefits the Company. B. Individuals are reluctant to serve as directors or officers of corporations or in certain other capacit |
|
| February 5, 2026 |
Exhibit 3.8 FOURTH amended and restated CERTIFICATE OF INCORPORATION OF Corvex, Inc. (Originally incorporated under the Delaware General Corporation Law on January 30, 2018 under the name Maestro Sensors Inc.) This Fourth Amended and Restated Certificate of Incorporation (“Certificate of Incorporation”) of the Corporation, which restates and integrates and further amends the provisions of the Corp |
|
| February 5, 2026 |
Exhibit 99.1 Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. V82202 - TBD For Against Abstain O O O O O O O O O O O O MOVANO INC. 6800 KOLL CENTER PARKWAY PLEASANTON, CA 94566 ATTN: SECRETARY Th |
|
| January 23, 2026 |
Filed by Movano Inc. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Movano Inc. Commission File No.: 001-40254 Date: January 22, 2026 Corvex Secures Long-Term NVIDIA H200 GPU Deployment with AI-driven Provider of High-Performance Battery Technologies to Support Production AI Workloads Arlingt |
|
| January 13, 2026 |
As filed with the Securities and Exchange Commission on January 13, 2026. As filed with the Securities and Exchange Commission on January 13, 2026. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 3845 82-4233771 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employ |
|
| January 13, 2026 |
CALCULATION OF FILING FEE TABLES MOVANO INC. Table 1: Newly Registered and Carry Forward Securities Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-1 MOVANO INC. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Stock, $0.0001 par |
|
| December 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 22, 2025 |
As filed with the Securities and Exchange Commission on December 19, 2025 As filed with the Securities and Exchange Commission on December 19, 2025 Registration No. |
|
| December 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 22, 2025 |
Calculation of Filing Fee Tables S-4 Movano Inc. Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial Effecti |
|
| December 22, 2025 |
CALCULATION OF FILING FEE TABLES MOVANO INC. Table 1: Newly Registered and Carry Forward Securities Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-1 MOVANO INC. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Stock, $0.0001 par |
|
| December 22, 2025 |
Consent to be Named as a Director Exhibit 99.3 Consent to be Named as a Director In connection with the filing by Movano Inc. (the “Company”) of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and |
|
| December 22, 2025 |
Exhibit 21.1 SUBSIDIARIES OF MOVANO INC. Registrant’s consolidated subsidiaries are shown below, together with the state or jurisdiction of organization of each subsidiary and the percentage of voting securities that Registrant owns in each subsidiary. Name of Subsidiary Jurisdiction of Incorporation or Organization Percent of Outstanding Voting Securities Owned as of September 30, 2025 Movano Ire |
|
| December 22, 2025 |
MOVANO INC. Index to Consolidated Financial Statements Exhibit 99.1 MOVANO INC. Index to Consolidated Financial Statements Page(s) Audited Financial Statements as of and for the Years Ended December 31, 2024 and 2023: Report of Independent Registered Public Accounting Firm (Baker Tilly US, LLP, San Francisco, California, PCAOB ID: 23) F-2 Consolidated Balance Sheets at December 31, 2024 and 2023 F-3 Consolidated Statements of Operations and Comprehens |
|
| December 22, 2025 |
Consent to be Named as a Director Exhibit 99.2 Consent to be Named as a Director In connection with the filing by Movano Inc. (the “Company”) of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and |
|
| December 22, 2025 |
As filed with the U.S. Securities and Exchange Commission on December 19, 2025 As filed with the U.S. Securities and Exchange Commission on December 19, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-4 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 3845 82-4233771 (State or other jurisdiction of incorporation or organization) (Primar |
|
| December 22, 2025 |
CALCULATION OF FILING FEE TABLES Movano Inc. Table 1: Newly Registered Securities Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-8 Movano Inc. Table 1: Newly Registered Securities Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.0001 per share (1) Other 500,000 $ 7.51 $ 3,755,000.00 0.0001381 $ 518.57 T |
|
| December 22, 2025 |
Exhibit 10.27 KLUSTR, INC. 2024 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: November 5, 2024 APPROVED BY THE STOCKHOLDERS: November 5, 2024 TERMINATION DATE: November 4, 2034 1. General. (a) Eligible Stock Award Recipients. Employees, Directors and Consultants are eligible to receive Stock Awards. (b) Available Stock Awards. The Plan provides for the grant of the following types of St |
|
| December 22, 2025 |
As filed with the Securities and Exchange Commission on December 19, 2025. As filed with the Securities and Exchange Commission on December 19, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 3845 82-4233771 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Emplo |
|
| December 22, 2025 |
MOVANO INC. Index to Consolidated Financial Statements Exhibit 99.1 MOVANO INC. Index to Consolidated Financial Statements Page(s) Audited Financial Statements as of and for the Years Ended December 31, 2024 and 2023: Report of Independent Registered Public Accounting Firm (Baker Tilly US, LLP, San Francisco, California, PCAOB ID: 23) F-2 Consolidated Balance Sheets at December 31, 2024 and 2023 F-3 Consolidated Statements of Operations and Comprehens |
|
| December 17, 2025 |
Amendment No. 3 of the Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan Exhibit 10.1 Amendment No. 3 of the Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan This Amendment No. 3 (“Amendment”), dated November 10, 2025, of the Amended and Restated 2019 Omnibus Incentive Plan (the “Existing Plan”; as amended by Amendment No. 1, dated April 15, 2022 and by Amendment No. 2, dated May 15, 2024, and as amended hereby, the “Plan”), of Movano Inc., a Delaware corpo |
|
| December 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 17, 2025 |
Amendment No. 3 of the Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan Exhibit 10.1 Amendment No. 3 of the Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan This Amendment No. 3 (“Amendment”), dated November 10, 2025, of the Amended and Restated 2019 Omnibus Incentive Plan (the “Existing Plan”; as amended by Amendment No. 1, dated April 15, 2022 and by Amendment No. 2, dated May 15, 2024, and as amended hereby, the “Plan”), of Movano Inc., a Delaware corpo |
|
| November 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Con |
|
| November 14, 2025 |
FIRST AMENDMENT TO LOAN AGREEMENT Exhibit 10.2 FIRST AMENDMENT TO LOAN AGREEMENT THIS FIRST AMENDMENT TO LOAN AGREEMENT (this “Amendment”) is made and entered into as of November 3, 2025, by and between EVIE HOLDINGS, LLC (“Lender”) and MOVANO Inc., a Delaware corporation (the “Borrower”). RECITALS A. On August 6, 2025, Lender made a loan to Borrower in the original principal amount of One Million Five Hundred Thousand Dollars ($1 |
|
| November 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant a |
|
| November 14, 2025 |
SECOND AMENDMENT TO LOAN AGREEMENT Exhibit 10.3 SECOND AMENDMENT TO LOAN AGREEMENT THIS SECOND AMENDMENT TO LOAN AGREEMENT (this “Amendment”) is made and entered into as of November 6, 2025, by and between EVIE HOLDINGS, LLC (“Lender”) and MOVANO Inc., a Delaware corporation (the “Borrower”). RECITALS A. On August 6, 2025, Lender made a loan to Borrower in the original principal amount of One Million Five Hundred Thousand Dollars ( |
|
| November 14, 2025 |
Exhibit 10.1 LOAN AGREEMENT dated as of August 6, 2025 among MOVANO INC. as Borrower and EVIE HOLDINGS, LLC as Lender TABLE OF CONTENTS PAGE ARTICLE 1 Definitions Section 1.01. Defined Terms 1 Section 1.02. Terms Generally 8 ARTICLE 2 The Loan Section 2.01. Commitment 9 Section 2.02. Borrowing Request Section 2.03. Repayment of Loan; Evidence of Debt 9 Section 2.04. Prepayment of Loans 9 Section 2 |
|
| November 14, 2025 |
Exhibit 10.4 SECURITY AGREEMENT This Security Agreement (as amended, modified or otherwise supplemented from time to time, this “Security Agreement”), dated as of August 6, 2025, is executed by MOVANO INC., a Delaware corporation (“Company”), in favor of EVIE HOLDINGS, LLC (“Lender”). RECITALS A. Company and Lender are entering into a Loan Agreement, dated as of the date hereof (as amended from ti |
|
| November 14, 2025 |
INTELLECTUAL PROPERTY SECURITY AGREEMENT Exhibit 10.5 INTELLECTUAL PROPERTY SECURITY AGREEMENT This Intellectual Property Security Agreement (this “Agreement”) is entered into as of August 6, 2025, by and between MOVANO INC., a Delaware corporation (“Borrower”) and EVIE HOLDINGS, LLC (“Lender”). RECITALS A. Lender has agreed to make a term loan to Borrower (the “Loan”) in the amount and manner set forth in that certain Loan Agreement dat |
|
| November 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Conf |
|
| November 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| November 10, 2025 |
FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT Exhibit 10.1 FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT This Parent Stockholder Support Agreement (this “Agreement”) is made as of November 6, 2025, by and among (i) Corvex, Inc., a Delaware corporation (the “Company”), and (ii) the undersigned stockholder (“Holder”) of Parent. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Merger A |
|
| November 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| November 10, 2025 |
Exhibit 10.5 Execution Version REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 6, 2025 is by and between Chardan Capital Markets LLC, a New York limited liability company (the “Investor”), and Movano Inc., a Delaware corporation (the “Company”). RECITALS The Company and the Investor have entered into that certain ChEF Purchase Agreement, da |
|
| November 10, 2025 |
CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES A CONVERTIBLE PREFERRED STOCK Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES A CONVERTIBLE PREFERRED STOCK Movano Inc., a Delaware corporation (hereinafter called the “Corporation”), DOES HEREBY CERTIFY hereby certifies that the following resolution has been duly adopted by the Board of Directors of the Corporation (the “Board”) as required by Section 151 of the General Corporation Law of the State of Delaware ( |
|
| November 10, 2025 |
Exhibit 10.2 FORM OF LOCK-UP AGREEMENT This LOCK-UP AGREEMENT (this “Agreement”), dated as of November 6, 2025, is entered into by and among Movano Inc., a Delaware corporation (the “Parent”), Corvex, Inc., a Delaware corporation (the “Company”), and the undersigned (the “Securityholder” and together with the Parent and the Company, the “Parties” and each a “Party”). WHEREAS, the Parent, Thor Merg |
|
| November 10, 2025 |
Exhibit 99.1 CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE ● Strategic combination positions combined company to capture AI infrastructure demand at scale ● Movano (Nasdaq: MOVE) shareholders gain exposure to rapidly emerging AI infrastructure pure play platform with differentiated product offering, a |
|
| November 10, 2025 |
FORM OF PREFERRED STOCK SUBSCRIPTION AGREEMENT Exhibit 10.3 FORM OF PREFERRED STOCK SUBSCRIPTION AGREEMENT This Preferred Stock Subscription Agreement (this “Subscription Agreement”) is made and entered into by and among Movano Inc., a Delaware corporation (the “Company”) and the investors listed on the signature pages hereto (each an “Investor” and together, the “Investors”) in connection with the proposed business combination (the “Merger”) |
|
| November 10, 2025 |
FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT Exhibit 10.1 FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT This Parent Stockholder Support Agreement (this “Agreement”) is made as of November 6, 2025, by and among (i) Corvex, Inc., a Delaware corporation (the “Company”), and (ii) the undersigned stockholder (“Holder”) of Parent. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Merger A |
|
| November 10, 2025 |
Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among: MOVANO INC., a Delaware corporation, THOR MERGER SUB INC., a Delaware corporation, and CORVEX, INC., a Delaware corporation Made and entered into as of November 6, 2025 TABLE OF CONTENTS Page Section 1. DESCRIPTION OF TRANSACTION 2 1.1. The Merger 2 1.2. Effects of the Merger 2 1.3. Closing; Effective Time 3 1.4. Certificate |
|
| November 10, 2025 |
FORM OF PREFERRED STOCK SUBSCRIPTION AGREEMENT Exhibit 10.3 FORM OF PREFERRED STOCK SUBSCRIPTION AGREEMENT This Preferred Stock Subscription Agreement (this “Subscription Agreement”) is made and entered into by and among Movano Inc., a Delaware corporation (the “Company”) and the investors listed on the signature pages hereto (each an “Investor” and together, the “Investors”) in connection with the proposed business combination (the “Merger”) |
|
| November 10, 2025 |
Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among: MOVANO INC., a Delaware corporation, THOR MERGER SUB INC., a Delaware corporation, and CORVEX, INC., a Delaware corporation Made and entered into as of November 6, 2025 TABLE OF CONTENTS Page Section 1. DESCRIPTION OF TRANSACTION 2 1.1. The Merger 2 1.2. Effects of the Merger 2 1.3. Closing; Effective Time 3 1.4. Certificate |
|
| November 10, 2025 |
Exhibit 99.1 CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE ● Strategic combination positions combined company to capture AI infrastructure demand at scale ● Movano (Nasdaq: MOVE) shareholders gain exposure to rapidly emerging AI infrastructure pure play platform with differentiated product offering, a |
|
| November 10, 2025 |
Exhibit 10.4 ChEF PURCHASE AGREEMENT This ChEF PURCHASE AGREEMENT is made and entered into as of November 6, 2025 (together with Annex I, this “Agreement”), by and between Chardan Capital Markets LLC, a New York limited liability company (the “Investor”), and Movano Inc., a Delaware corporation (the “Company”). RECITALS WHEREAS, the parties desire that, upon the terms and subject to the conditions |
|
| November 10, 2025 |
Exhibit 10.2 FORM OF LOCK-UP AGREEMENT This LOCK-UP AGREEMENT (this “Agreement”), dated as of November 6, 2025, is entered into by and among Movano Inc., a Delaware corporation (the “Parent”), Corvex, Inc., a Delaware corporation (the “Company”), and the undersigned (the “Securityholder” and together with the Parent and the Company, the “Parties” and each a “Party”). WHEREAS, the Parent, Thor Merg |
|
| November 10, 2025 |
Exhibit 10.5 Execution Version REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 6, 2025 is by and between Chardan Capital Markets LLC, a New York limited liability company (the “Investor”), and Movano Inc., a Delaware corporation (the “Company”). RECITALS The Company and the Investor have entered into that certain ChEF Purchase Agreement, da |
|
| November 10, 2025 |
CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES A CONVERTIBLE PREFERRED STOCK Exhibit 3.1 CERTIFICATE OF DESIGNATIONS OF MOVANO INC. SERIES A CONVERTIBLE PREFERRED STOCK Movano Inc., a Delaware corporation (hereinafter called the “Corporation”), DOES HEREBY CERTIFY hereby certifies that the following resolution has been duly adopted by the Board of Directors of the Corporation (the “Board”) as required by Section 151 of the General Corporation Law of the State of Delaware ( |
|
| November 10, 2025 |
Exhibit 10.4 ChEF PURCHASE AGREEMENT This ChEF PURCHASE AGREEMENT is made and entered into as of November 6, 2025 (together with Annex I, this “Agreement”), by and between Chardan Capital Markets LLC, a New York limited liability company (the “Investor”), and Movano Inc., a Delaware corporation (the “Company”). RECITALS WHEREAS, the parties desire that, upon the terms and subject to the conditions |
|
| November 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| October 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| October 8, 2025 |
CERTIFICATE OF AMENDMENT THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION MOVANO INC. Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION MOVANO INC. MOVANO INC., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify that: 1. The Third Amended and Restated Certificate of Incorporation of the Corporation (as amended) is hereby amended by deleting the te |
|
| October 8, 2025 |
CERTIFICATE OF AMENDMENT THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION MOVANO INC. Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. MOVANO INC., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify that: 1. The Third Amended and Restated Certificate of Incorporation of the Corporation (as amended) is hereby amended by deleting th |
|
| October 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number |
|
| October 8, 2025 |
Exhibit 99.1 Movano Health Announces Reverse Stock Split Shares Expected to Begin Trading on Split-Adjusted Basis on October 10, 2025 PLEASANTON, CA October 8, 2025 - Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-10 reverse stock split of its common stock (the “Reverse Stock Split”), effective at 12:01 a.m. Eastern time on October 10, 2025. The Company’s common stock |
|
| October 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number |
|
| September 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Num |
|
| September 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as spe |
|
| September 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED march 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as sp |
|
| August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Con |
|
| August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exact na |
|
| August 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 28, 2025 |
Movano Health Granted Listing Extension by Nasdaq Exhibit 99.1 Movano Health Granted Listing Extension by Nasdaq PLEASANTON, CA August 28, 2025 - Movano Health (Nasdaq: MOVE)(the “Company”) announced today that, by letter received on August 27, 2025, the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) has determined to grant the Company’s request to continue its listing on Nasdaq, subject to (i) the Company regaining |
|
| August 22, 2025 |
Exhibit 99.1 Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q PLEASANTON, CA August 22, 2025 - Movano Health (Nasdaq: MOVE)(the “Company”) announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that because the Company had not yet fil |
|
| August 22, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number |
|
| August 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Conf |
|
| August 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 13, 2025 MOVANO INC. |
|
| August 15, 2025 |
SEC File Number 001-40254 CUSIP Number 62459M 206 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2025 MOVANO INC. |
|
| July 11, 2025 |
Exhibit 99.1 Movano Health Plans to Timely Request a Hearing before a Nasdaq Hearings Panel Received Delisting Notice from Nasdaq Related to Minimum Bid Price Requirement and Late Filing of the Form 10-Q for the period ended March 31, 2025 PLEASANTON, CA July 11, 2025 - Movano Health (Nasdaq: MOVE) (the “Company”) announced today that, on July 7, 2025, it received a delisting determination from Th |
|
| July 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 7, 2025 MOVANO INC. |
|
| June 25, 2025 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 24, 2025 MOVANO INC. |
|
| June 25, 2025 |
Exhibit 16.1 June 25, 2025 U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Ladies and Gentlemen: We have read the statements made by the Movano Inc. included under Item 4.01 of its Current Report on Form 8-K dated June 24, 2025 to be filed with the Securities and Exchange Commission. We agree with the statements concerning our Firm contained therein. Sincerely, /s/ Mo |
|
| May 23, 2025 |
Exhibit 99.1 Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q PLEASANTON, CA May 23, 2025 - Movano Health (Nasdaq: MOVE)(the “Company”) announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that because the Company had not yet filed |
|
| May 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2025 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 21, 2025 |
SEC File Number 001-40254 CUSIP Number 62459M107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 19, 2025 |
Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 15, 2025 MOVANO INC. |
|
| April 9, 2025 |
Exhibit 10.19 FIRST AMENDMENT TO LEASE THIS FIRST AMENDMENT TO LEASE (“Amendment”) is made and entered into as of the 22nd day of April, 2022, by and between BERNAL CORPORATE PARK II-E, LLC, a Delaware limited liability company (“Landlord”), and MOYANO INC., a Delaware corporation (“Tenant”). R E C I T A L S : A. Landlord and Tenant entered into that certain Office Lease dated as of March 29, 2021 |
|
| April 9, 2025 |
Exhibit 21.1 SUBSIDIARIES OF MOVANO INC. Registrant’s consolidated subsidiaries are shown below, together with the state or jurisdiction of organization of each subsidiary and the percentage of voting securities that Registrant owns in each subsidiary. Name of Subsidiary Jurisdiction of Incorporation or Organization Percent of Outstanding Voting Securities Owned as of December 31, 2024 Movano Irel |
|
| April 9, 2025 |
Exhibit 19.1 Movano Inc. Insider Trading Policy Movano Inc. (the “Company”) has adopted this Insider Trading Policy (the “Policy”) to promote compliance with federal securities laws by directors, officers, employees and consultants of the Company and its affiliates, as well as any immediate family members sharing the household of any of the foregoing, and any entities controlled by any of the fore |
|
| April 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exac |
|
| April 9, 2025 |
Office Lease, dated March 29, 2021, by and between Bernal Corporate Park II-E, LLC and the Company Exhibit 10.18 OFFICE LEASE BERNAL CORPORATE PARK BERNAL CORPORATE PLAZA II BERNAL CORPORATE PARK II-E, LLC, a Delaware limited liability company, as Landlord, and MOVANO INC., a Delaware corporation, as Tenant. BERNAL CORPORATE PARK BERNAL CORPORATE PLAZA II SUMMARY OF BASIC LEASE INFORMATION The parties hereto agree to the following terms of this Summary of Basic Lease Information (the “Summary”) |
|
| April 9, 2025 |
MOVANO INC. Up to $8,886,273 Common Stock Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-264116 AMENDMENT NO. 3 DATED APRIL 9, 2025 To Prospectus Supplements dated August 15, 2022, May 29, 2024 and September 16, 2024 (To Prospectus dated May 25, 2022) MOVANO INC. Up to $8,886,273 Common Stock This Amendment No. 3 to Prospectus Supplements (the “Amendment”) amends and supplements the information in our prospectus, dated Ma |
|
| April 9, 2025 |
Exhibit 10.20 SECOND AMENDMENT TO LEASE THIS SECOND AMENDMENT TO LEASE (“Amendment”) is made and entered into as of the 9th day of January, 2024, but is retroactively effective as of December 1, 2023, by and between BERNAL CORPORATE PARK 11-E, LLC, a Delaware limited liability company (“Landlord”), and MOVANO INC., a Delaware corporation (“Tenant”). R E C I T A L S : A. Landlord and Tenant entered |
|
| April 9, 2025 |
Exhibit 10.21 THIRD AMENDMENT TO LEASE THIS THIRD AMENDMENT TO LEASE ("Amendment") is made and entered into as of the 19th day of June, 2024 by and between BERNAL CORPORATE PARK II-E, LLC, a Delaware limited liability company ("Landlord"), and MOVANO INC., a Delaware corporation ("Tenant"). R E C I T A L S : A. Landlord and Tenant entered into that certain Office Lease dated as of March 29, 2021 ( |
|
| March 31, 2025 |
SEC File Number 001-40254 CUSIP Number 62459M107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 2, 2025 Movano Inc. |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant a |
|
| November 14, 2024 |
Exhibit 99 Movano Health Reports Q3 2024 Financial Results and Provides Business Update Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. |
|
| November 14, 2024 |
Form of Warrant issued in August 2024 Exhibit 4.11 WARRANT NEITHER THESE SECURITIES NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND APPLICABLE STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFF |
|
| November 14, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2024 Movano Inc. |
|
| October 25, 2024 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. MOVANO INC., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify that: 1. The Third Amended and Restated Certificate of Incorporation of the Corporation is hereby amended by adding the following para |
|
| October 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2024 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| October 25, 2024 |
Exhibit 99.1 Movano Health Announces Reverse Stock Split Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024 PLEASANTON, CA October 25, 2024 - Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the “Reverse Stock Split”), effective at 12:01 a.m. Eastern time on October 29, 2024. The C |
|
| September 16, 2024 |
MOVANO INC. Up to $8,259,292 Common Stock Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-264116 AMENDMENT NO. 2 DATED SEPTEMBER 16, 2024 To Prospectus Supplements dated August 15, 2022 and May 29, 2024 (To Prospectus dated May 25, 2022) MOVANO INC. Up to $8,259,292 Common Stock This Amendment No. 2 to Prospectus Supplements (the “Amendment”) amends and supplements the information in our prospectus, dated May 25, 2022 (the |
|
| August 16, 2024 |
As filed with the Securities and Exchange Commission on August 15, 2024 As filed with the Securities and Exchange Commission on August 15, 2024 Registration No. |
|
| August 16, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Movano Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equit |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as spe |
|
| August 14, 2024 |
Exhibit 99 Movano Health Reports Q2 2024 Financial Results and Provides Business Update Prepares for September 17, 2024, Evie Ring back in stock date Announces brand partnership with digital creator Heidi D’Amelio Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. |
|
| August 14, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 14, 2024 Movano Inc. |
|
| July 10, 2024 |
Amendment No. 2 to Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan Exhibit 10.1 Amendment No. 2 of the Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan This Amendment No. 2 (“Amendment”), dated May 15, 2024, of the Amended and Restated 2019 Omnibus Incentive Plan (the “Existing Plan”; as amended by Amendment No. 1, dated April 15, 2022, and as amended hereby, the “Plan”), of Movano Inc., a Delaware corporation (the “Company”), is made and adopted by t |
|
| July 10, 2024 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. MOVANO INC., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify that: 1. The Third Amended and Restated Certificate of Incorporation of the Corporation is hereby amended by deleting the first paragr |
|
| July 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2024 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 29, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 29, 2024 MOVANO INC. |
|
| May 29, 2024 |
MOVANO INC. Up to $3,406,141 Common Stock Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-264116 AMENDMENT NO. 1 DATED MAY 29, 2024 To Prospectus Supplement dated August 15, 2022 (To Prospectus dated May 25, 2022) MOVANO INC. Up to $3,406,141 Common Stock This Amendment No. 1 to Prospectus Supplement, or this Amendment, amends our prospectus supplement dated August 15, 2022, or the Prospectus Supplement. This Amendment sho |
|
| May 29, 2024 |
Amendment No. 1 to At the Market Issuance Agreement, dated May 29, 2024 Exhibit 10.1 AMENDMENT NO. 1 TO AT THE MARKET ISSUANCE AGREEMENT May 29, 2024 B. Riley Securities, Inc. 299 Park Avenue, 21st Floor New York, New York 10171 JonesTrading Institutional Services LLC 325 Hudson St., 6th Floor New York, NY 10013 Ladies and Gentlemen: Movano Inc., a Delaware corporation (the “Company”) and B. Riley Securities, Inc. (“B. Riley”) are parties to that certain At the Market |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Co |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ց ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 տ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exac |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as sp |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Con |
|
| May 15, 2024 |
Exhibit 99.1 Movano Health Reports Q1 2024 Financial Results and Provides Business Update Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. – May 15, 2024 – Movano Health (Nasdaq: MOVE), a pione |
|
| May 15, 2024 |
SEC File Number 001-40254 CUSIP Number 62459M107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 15, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2024 Movano Inc. |
|
| May 8, 2024 |
Filed Pursuant to Rule 424(b)(7) Registration No. 333-278885 PROSPECTUS MOVANO INC. 36,594,656 Shares of Common Stock 39,015,499 Shares of Common Stock Underlying Warrants 2,420,843 Shares of Common Stock Underlying Pre-Funded Warrants This prospectus relates to up to 78,030,998 shares of common stock, par value $0.0001 per share, that the selling stockholders identified in this prospectus may sel |
|
| May 3, 2024 |
Movano Inc. 6800 Koll Center Parkway, Pleasanton, CA 94566 Movano Inc. 6800 Koll Center Parkway, Pleasanton, CA 94566 May 3, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: J. Conlon Danberg Re: Movano Inc. Registration Statement on Form S-3 File No. 333-278885 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), registrant Movano Inc. (the |
|
| April 30, 2024 |
United States securities and exchange commission logo April 30, 2024 John Mastrototaro Chief Executive Officer Movano Inc. |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 |
|
| April 23, 2024 |
As filed with the Securities and Exchange Commission on April 23, 2024 As filed with the Securities and Exchange Commission on April 23, 2024 Registration No. |
|
| April 23, 2024 |
Filing Fee Table (filed herewith) Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Movano Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee New |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exac |
|
| April 16, 2024 |
Exhibit 21.1 SUBSIDIARIES OF MOVANO INC. Registrant’s consolidated subsidiaries are shown below, together with the state or jurisdiction of organization of each subsidiary and the percentage of voting securities that Registrant owns in each subsidiary. Name of Subsidiary Jurisdiction of Incorporation or Organization Percent of Outstanding Voting Securities Owned as of December 31, 2023 Movano Irel |
|
| April 16, 2024 |
Incentive-Based Compensation Recovery Policy Exhibit 97.1 Movano Inc. Incentive-BASED Compensation Recovery Policy 1. Policy Purpose. The purpose of this Movano Inc. (the “Company”) Incentive-Based Compensation Recovery Policy (this “Policy”) is to enable the Company to recover Erroneously Awarded Compensation in the event that the Company is required to prepare an Accounting Restatement. This Policy is intended to comply with the requiremen |
|
| April 10, 2024 |
MOVE / Movano Inc. / APPEL PETER A - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| April 9, 2024 |
MOVE / Movano Inc. / Tamkin Gregory S - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. |
|
| April 9, 2024 |
EX-99.1 2 ea020358501ex99-1movano.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of a statement on Schedule 13G and any and all amendments thereto as well as any other form(s), statement |
|
| April 4, 2024 |
Exhibit 99.1 Movano Health Reports 2023 Financial Results and Provides Business Update Executes $24 million funding extending cash runway Focuses on 2024 strategic pathway to FDA clearances driving B2B opportunities Plans launch of Evie Med Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. – April 4, 2024 – Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported fou |
|
| April 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 4, 2024 Movano Inc. |
|
| April 3, 2024 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| April 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 2, 2024 MOVANO INC. |
|
| April 3, 2024 |
Form of Securities Purchase Agreement, dated April 2, 2024 Exhibit 10.1 MOVANO INC. SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of April 2, 2024, between Movano Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers attached hereto as Addendum A (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the |
|
| April 3, 2024 |
Form of Registration Rights Agreement Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of , 2024, between Movano, Inc., a Delaware corporation (the “Company”), and the persons listed on the Schedule of Buyers attached to the Purchase Agreement (as defined below) (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pu |
|
| April 3, 2024 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| April 1, 2024 |
SEC File Number 001-40254 CUSIP Number 62459M107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 29, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 29, 2023 MOVANO INC. |
|
| November 29, 2023 |
Exhibit 99.1 Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement Pleasanton, Calif. – Nov. 29, 2023 – Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announces the successful ecommerce launch of the Evie Ring, the innovative smart ring designed for women, which has exceeded the Company’s |
|
| November 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 14, 2023 MOVANO INC. |
|
| November 16, 2023 |
4,235,304 Shares of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 PROSPECTUS SUPPLEMENT (to the Prospectus dated May 25, 2022) 4,235,304 Shares of Common Stock We are offering 4,235,304 shares of our common stock pursuant to this prospectus supplement and accompanying prospectus. The public offering price for each share of common stock is $0.85. See “Description of Securities We Are Offering” in this p |
|
| November 15, 2023 |
Exhibit 99.1 Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results Conference call begins at 8:30 a.m. Pacific time today Pleasanton, Calif. – November 15, 2023 – Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, reported financial results for the thre |
|
| November 15, 2023 |
Exhibit 1.1 4,235,304 Shares MOVANO INC. COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT November 14, 2023 November 14, 2023 The Benchmark Company, LLC As the Representative of the several underwriters 150 East 58th St., 17th Floor New York, NY 10155 Ladies and Gentlemen: Movano Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters nam |
|
| November 15, 2023 |
Movano Health Announces Proposed Public Offering Exhibit 99.1 Movano Health Announces Proposed Public Offering PLEASANTON, Calif., November 14, 2023 – Movano Health (Nasdaq: MOVE) (“Movano Health” or the “Company”), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it is proposing to sell shares of its common stock in an underwritten public offering |
|
| November 15, 2023 |
Movano Health Prices $3.6 Million Public Offering Exhibit 99.2 Movano Health Prices $3.6 Million Public Offering PLEASANTON, Calif., November 15, 2023 – Movano Health (Nasdaq: MOVE) (“Movano Health” or the “Company”), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it has priced a $3.6 million underwritten public offering of 4,235,304 shares of its |
|
| November 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 15, 2023 Movano Inc. |
|
| November 15, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 14, 2023 MOVANO INC. |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant a |
|
| November 14, 2023 |
SUBJECT TO COMPLETION, DATED NOVEMBER 14, 2023 Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but the information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell nor do they s |
|
| August 14, 2023 |
Exhibit 99 Movano Health Provides Business Update and Reports Second Quarter 2023 Financial Results Conference call begins at 2:00 p. |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as spe |
|
| August 14, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 14, 2023 Movano Inc. |
|
| June 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2023 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 82-4233771 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 21, 2023 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MOVANO INC. MOVANO INC., a corporation duly organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify that: 1. The Third Amended and Restated Certificate of Incorporation of the Corporation is hereby amended by deleting the first paragr |
|
| June 14, 2023 |
8,000,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 PRELIMINARY PROSPECTUS SUPPLEMENT (to the Prospectus dated May 25, 2022) 8,000,000 Shares of Common Stock We are offering 8,000,000 shares of our common stock pursuant to this prospectus supplement and accompanying prospectus. The public offering price for each share of common stock is $1.00. See “Description of Securities We Are Offerin |
|
| June 13, 2023 |
Movano Health Announces Proposed Public Offering Exhibit 99.1 Movano Health Announces Proposed Public Offering Pleasanton, Calif., June 12, 2023 –Movano Health (Nasdaq: MOVE) (“Movano Health” or the “Company”), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it is proposing to sell shares of its common stock in an underwritten public offering. All |
|
| June 13, 2023 |
Underwriting Agreement dated as of June 13, 2023 between the Company and The Benchmark Company, LLC* Exhibit 1.1 8,000,000 Shares MOVANO INC. COMMON STOCK PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT June 13, 2023 June 13, 2023 The Benchmark Company, LLC As the Representative of the several underwriters 150 East 58th St., 17th Floor New York, NY 10155 Ladies and Gentlemen: Movano Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Sc |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 13, 2023 MOVANO INC. |
|
| June 13, 2023 |
Movano Health Prices $8.0 Million Public Offering Exhibit 99.2 Movano Health Prices $8.0 Million Public Offering Pleasanton, Calif., June 13, 2023 –Movano Health (Nasdaq: MOVE) (“Movano Health” or the “Company”), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it has priced an $8.0 million underwritten public offering of 8,000,000 shares of its com |
|
| June 12, 2023 |
SUBJECT TO COMPLETION, DATED JUNE 12, 2023 Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, as amended, but the information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell nor do they s |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as sp |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 15, 2023 Movano Inc. |
|
| May 15, 2023 |
Exhibit 99 Movano Health Provides Business Update and Reports First Quarter 2023 Financial Results Conference call begins at 9:00 a. |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ց ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 տ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exac |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confide |
|
| April 28, 2023 |
DEF 14A 1 ny20008282x2def14a.htm DEF14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate bo |
|
| April 17, 2023 |
PRE 14A 1 ny20008282x1pre14a.htm PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate b |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40254 MOVANO INC. (Exac |
|
| March 30, 2023 |
Exhibit 21.1 SUBSIDIARIES OF MOVANO INC. Registrant’s consolidated subsidiaries are shown below, together with the state or jurisdiction of organization of each subsidiary and the percentage of voting securities that Registrant owns in each subsidiary. Name of Subsidiary Jurisdiction of Incorporation or Organization Percent of Outstanding Voting Securities Owned as of December 31, 2022 Movano Irel |
|
| March 20, 2023 |
Exhibit 99 Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results Conference call begins at 9:00 a. |
|
| March 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 20, 2023 Movano Inc. |
|
| January 31, 2023 |
Exhibit 4.2 WARRANT AGENT AGREEMENT WARRANT AGENT AGREEMENT (this “Warrant Agreement”) dated as of January 31, 2023 (the “Issuance Date”) between Movano Inc., a company incorporated under the laws of the State of Delaware (the “Company”), and Pacific Stock Transfer Company, a Nevada Corporation (the “Warrant Agent”). WHEREAS, pursuant to the terms of that certain Underwriting Agreement (“Underwrit |
|
| January 31, 2023 |
4,644,000 Shares of Common Stock Warrants to Purchase up to 2,322,000 Shares of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 PROSPECTUS SUPPLEMENT (to the Prospectus dated May 25, 2022) 4,644,000 Shares of Common Stock Warrants to Purchase up to 2,322,000 Shares of Common Stock We are offering 4,644,000 shares of our common stock and warrants to purchase up to 2,322,000 shares of our common stock pursuant to this prospectus supplement and accompanying prospect |
|
| January 31, 2023 |
Movano Health Prices $6.5 Million Public Offering Exhibit 99.2 Movano Health Prices $6.5 Million Public Offering Pleasanton, Calif., Jan. 27, 2023 –Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it has priced a $6.5 million underwritten public offering of 4,644,000 shares of its common stock and warrants to purchase u |
|
| January 31, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 27, 2023 MOVANO INC. |
|
| January 31, 2023 |
Exhibit 1.1 UNDERWRITING AGREEMENT between MOVANO INC. and NEWBRIDGE SECURITIES CORPORATION Common Stock January 27, 2023 Newbridge Securities Corporation 1200 North Federal Highway, Suite 400 Boca Raton, Florida 33432 Ladies and Gentlemen: The undersigned, Movano Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) wi |
|
| January 31, 2023 |
Movano Health Announces Proposed Public Offering Exhibit 99.1 Movano Health Announces Proposed Public Offering Pleasanton, Calif., Jan. 26, 2023 –Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today announced that it is proposing to sell shares of its common stock and warrants to purchase common stock in an underwritten public offering. |
|
| January 31, 2023 |
Form of Warrant to Purchase Common Stock Exhibit 4.1 COMMON STOCK PURCHASE WARRANT MOVANO INC. Warrant Shares: Initial Issue Date: January 31, 2023 Initial Exercise Date: January 31, 2023 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after |
|
| January 26, 2023 |
SUBJECT TO COMPLETION, DATED JANUARY 26, 2023 Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 This preliminary prospectus supplement relates to an effective registration statement under the Securities Act of 1933, but the information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell nor do they seek an offer |
|
| November 14, 2022 |
Exhibit 99.1 Movano Health Provides Business Update and Reports Third Quarter 2022 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? November 14, 2022 ? Today, Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, reported financial results for the three months endi |
|
| November 14, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2022 Movano Inc. |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant a |
|
| August 15, 2022 |
Movano Inc. 2021 Inducement Award Plan * Exhibit 4.6 MOVANO INC. 2021 INDUCEMENT AWARD PLAN Movano Inc., a Delaware corporation sets forth herein the terms of its 2021 Inducement Award Plan. 1. PURPOSE The purpose of the Plan is to provide, among other equity awards, non-qualified stock options to individuals not previously employees of the Company (or following such individuals? bona fide period of non-employment with the Company), as a |
|
| August 15, 2022 |
Exhibit 107 Calculation of Filing Fee Tables ??Form S-8??.. (Form Type) ?????.????? Movano Inc. ??????????.. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price Fee Rate A |
|
| August 15, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 15, 2022 Movano Inc. |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as spe |
|
| August 15, 2022 |
EX-1.1 2 f10q0622ex1-1movano.htm AT THE MARKET ISSUANCE AGREEMENT, DATED AUGUST 15, 2022 BY AND BETWEEN THE COMPANY, AS ISSUER, AND B. RILEY SECURITIES, INC. AS SALE AGENT Exhibit 1.1 Execution Version MOVANO INC. Common Stock, Par Value $0.0001 Per Share At the Market Issuance Agreement August 15, 2022 B. Riley Securities, Inc. 299 Park Avenue, 21st Floor New York, NY 10171 Ladies and Gentlemen: |
|
| August 15, 2022 |
MOVANO INC. Common Stock Having an Aggregate Offering Price of up to $50,000,000 424B5 1 ea164347-424b5movanoinc.htm PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(5) Registration No. 333-264116 PROSPECTUS SUPPLEMENT (to the Prospectus dated May 25, 2022) MOVANO INC. Common Stock Having an Aggregate Offering Price of up to $50,000,000 We have entered into an At the Market Issuance Agreement (the “Issuance Agreement”) with B. Riley Securities, Inc. (the “Sales Agent”) rela |
|
| August 15, 2022 |
Form Stock Option Award Agreement under Movano Inc. 2021 Inducement Award Plan * Exhibit 4.7 NOTICE OF GRANT OF STOCK OPTION MOVANO, INC. 2021 INDUCEMENT AWARD PLAN FOR GOOD AND VALUABLE CONSIDERATION, Movano, Inc. (the ?Company?) hereby grants, pursuant to the provisions of the Movano, Inc. 2021 Inducement Award Plan (the ?Plan?), to the Grantee designated below (?Grantee?) a Stock Option to purchase the number of Shares specified below (the ?Option?). The Option shall be sub |
|
| August 15, 2022 |
Exhibit 99 Movano Inc. Provides Business Update and Reports Second Quarter 2022 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? August 15, 2022 ? Today, Movano Inc. (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, reported financial results for the three months ending June 30, 2022 and pr |
|
| August 15, 2022 |
As filed with the Securities and Exchange Commission on August 15, 2022 As filed with the Securities and Exchange Commission on August 15, 2022 Registration No. |
|
| June 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2022 MOVANO INC. (Exact name of registrant as specified in its charter) Delaware 001-40254 26-0579295 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 22, 2022 |
Exhibit 10.1 Amendment No. 1 of the Movano Inc. Amended and Restated 2019 Omnibus Incentive Plan This Amendment No. 1 (?Amendment?), dated April 15, 2022, of the Amended and Restated 2019 Omnibus Incentive Plan (the ?Existing Plan?; as amended hereby, the ?Plan?), of Movano Inc., a Delaware corporation (the ?Company?), is made and adopted by the Company, subject to approval of the stockholders of |
|
| May 24, 2022 |
Movano Inc. 6800 Koll Center Parkway, Pleasanton, CA 94566 Movano Inc. 6800 Koll Center Parkway, Pleasanton, CA 94566 May 24, 2022 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Daniel Crawford Re: Movano Inc. Registration Statement on Form S-3 File No. 333-264116 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the ?Securities Act?), registrant Movano Inc. (the ? |
|
| May 19, 2022 |
As filed with the Securities and Exchange Commission on May 19, 2022 As filed with the Securities and Exchange Commission on May 19, 2022 Registration No. |
|
| May 12, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 12, 2022 Movano Inc. |
|
| May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER: 001-40254 MOVANO INC. (Exact name of registrant as sp |
|
| May 12, 2022 |
Exhibit 99.1 Movano Inc. Provides Business Update and Reports First Quarter 2022 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? May 12, 2022 ? Today, Movano Inc. (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, reported financial results for the three months ending March 31, 2022 and pro |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ?) Filed by the Registrant ? Filed by a Party other than the Registrant ?? Check the appropriate box: ?? Preliminary Proxy Statement ?? Con |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ?) Filed by the Registrant ? Filed by a Party other than the Registrant ?? Check the appropriate box: ?? Preliminary Proxy Statement ?? Con |
|
| April 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 15, 2022 Movano Inc. |
|
| April 18, 2022 |
Exhibit 99.1 Movano Welcomes Nan Kirsten Forte, a Pioneer and Innovator in Digital Health, as Its Newest Board Member Veteran health media executive joins the board of directors as Movano prepares for growth and commercialization Pleasanton, Calif., April 18, 2022 - Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announ |
|
| April 8, 2022 |
United States securities and exchange commission logo April 8, 2022 J. Cogan Chief Financial Officer Movano Inc. 6800 Koll Center Parkway Pleasanton, CA 94566 Re: Movano Inc. Registration Statement on Form S-3 Filed April 4, 2022 File No. 333-264116 Dear Mr. Cogan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 reg |
|
| April 4, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Movano Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forwa |
|
| April 4, 2022 |
Exhibit 4.8 INDENTURE between Movano Inc. and [] TRUSTEE Dated as of [] Providing for Issuance of Debt Securities in Series Reconciliation and tie between Indenture, dated as of , and the Trust Indenture Act of 1939, as amended. Trust Indenture Act of 1939 Section Indenture Section 310(a)(1) 6.11 (a)(2) 6.11 (a)(3) TIA (a)(4) Not Applicable (a)(5) TIA (b) 6.9; 6.11; TIA 311(a) TIA (b) TIA 312(a) 6 |
|
| April 4, 2022 |
As filed with the Securities and Exchange Commission on April 4, 2022 As filed with the Securities and Exchange Commission on April 4, 2022 Registration No. |
|
| March 30, 2022 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 24, 2022 Movano Inc. |
|
| March 30, 2022 |
Exhibit 99 Movano Inc. Provides Business Update and Reports Fourth Quarter 2021 Financial Results Conference call begins at 2:00 p.m. Pacific time today Pleasanton, Calif. ? March 24, 2022 ? Today, Movano Inc. (NASDAQ:MOVE) reported financial results for the three months ending December 31, 2021 and provided a business update. With a mission to empower and inspire you to live a healthier, happier |
